Guardion Health Sciences Reports 2019 Year End Results and Provides Corporate Update and Overview
30 mars 2020 09h00 HE
|
Guardion Health Sciences, Inc.
--Growing portfolio of synergistic assets and proprietary technologies --Focusing on scalable market opportunities to drive Company’s growth initiatives --Maintaining vision...
Guardion Health Sciences Granted 180-Day Extension by Nasdaq to Regain Compliance with Bid Price Rule
19 mars 2020 12h05 HE
|
Guardion Health Sciences, Inc.
- No immediate effect on the Company’s Nasdaq listing or the trading of its common stock - San Diego, California, March 19, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or...
Guardion Health Sciences Receives $3.5 Million from Exercise of Warrants
06 mars 2020 08h05 HE
|
Guardion Health Sciences, Inc.
San Diego, California, March 06, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), an ocular health sciences company that develops, formulates,...
Guardion Health Sciences Selected by Malaysian Listed Company to Develop an Immuno-Supportive Formula
26 févr. 2020 07h00 HE
|
Guardion Health Sciences, Inc.
Guardion® has signed a Letter of Appointment with Ho Wah Genting Berhad (HWGB) to create a new formula, designed to enhance the immune system.The formula will be a unique and exclusive brand of HWGB ...
Guardion® Announces Development of Unique Immuno-Supportive Complex Targeting Upper Respiratory Tract Infections
06 févr. 2020 07h00 HE
|
Guardion Health Sciences, Inc.
Formulation will be First Nutraceutical Compound to be Introduced Under Guardion’s Recently Acquired NutriGuard Business Line San Diego, California, Feb. 06, 2020 (GLOBE NEWSWIRE) --...
Guardion® Appoints Experienced Executive to Lead Development and Expansion of Recently-Acquired NutriGuard Business Line
07 janv. 2020 11h02 HE
|
Guardion Health Sciences, Inc.
San Diego, California, Jan. 07, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), a leader in the field of ocular health technologies and...
Guardion Health Sciences, Inc. Reports Results for the Three and Nine Months Ended September 30, 2019
14 nov. 2019 07h00 HE
|
Guardion Health Sciences, Inc.
Results Highlighted by 33% Increase in Revenues for Guardion’s Flagship Medical Food Lumega-Z® San Diego, CA, Nov. 14, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the...
Guardion Health Sciences Closes $8.4 Million Underwritten Public Offering
30 oct. 2019 12h33 HE
|
Guardion Health Sciences, Inc.
San Diego, CA, Oct. 30, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), today announced the closing of its previously announced underwritten...
Guardion Health Sciences Announces Pricing of $8.4 Million Underwritten Public Offering
28 oct. 2019 09h21 HE
|
Guardion Health Sciences, Inc.
San Diego, CA, Oct. 28, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), announced the pricing of an underwritten public offering of 24,500,000...
Guardion® Receives approval from USPTO for expanded claims for its Proprietary Medical Device, the MAPCAT SF
23 oct. 2019 07h00 HE
|
Guardion Health Sciences, Inc.
San Diego, California, Oct. 23, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI) announced that it has received approval from the USPTO for...